NEW YORK, May 26 (GenomeWeb News) - Tissue-banking firm Asterand will use DNA amplification technology developed by Rubicon Genomics as part of a collaborative diabetes study, Asterand said today.
Asterand said it will use Rubicon's GenomePlex whole-genome amplification technology to obtain DNA samples from relatives of diabetes patients in a collaborative study that involves researchers from
The trial will collect blood samples from people suffering from diabetes, but other family members "may prefer a simple mouthwash, and by using this new amplification technology we can get the information we need," said Asterand CSO James Eliason.
Asterand said it will begin using the amplification method in